|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| 05-20 | BioRegenx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-15 | BioRegenx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 7.77M 6.7M 6.31M 5.75M 10.8M 738M 10.86M 74.56M 29.02M 375M 29.18M 28.55M 1.24B | P/E 2024 |
-0.37x | P/E 2025 | -8.02x |
|---|---|---|---|---|---|
| Enterprise Value | 9.92M 8.56M 8.05M 7.33M 13.79M 941M 13.86M 95.13M 37.03M 479M 37.24M 36.43M 1.59B | EV / Sales 2024 |
4.58x | EV / Sales 2025 | 7.85x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
William Resides
CEO | Chief Executive Officer | 57 | 2024-03-07 |
Gary Hennerberg
SEC | Corporate Secretary | 69 | 2024-03-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Powers
BRD | Director/Board Member | 71 | 2011-12-31 |
William Resides
BRD | Director/Board Member | 57 | 2024-03-07 |
Suzanne Bird
BRD | Director/Board Member | 61 | 2024-03-07 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.34M 2.02M 1.9M 1.73M 3.25M 222M 3.27M 22.45M 8.74M 113M 8.79M 8.6M 375M | 1.85M 1.6M 1.5M 1.37M 2.58M 176M 2.59M 17.79M 6.92M 89.53M 6.96M 6.81M 297M |
| Net income | -23.05M -19.89M -18.71M -17.04M -32.05M -2.19B -32.22M -221M -86.07M -1.11B -86.56M -84.68M -3.69B | -1.54M -1.33M -1.25M -1.14M -2.15M -146M -2.16M -14.81M -5.76M -74.52M -5.8M -5.67M -247M |
| Net Debt | 2.11M 1.82M 1.71M 1.56M 2.93M 200M 2.94M 20.2M 7.86M 102M 7.91M 7.74M 337M | 2.15M 1.85M 1.74M 1.59M 2.98M 204M 3M 20.58M 8.01M 104M 8.05M 7.88M 343M |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
















